医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Cardihab Cardiac Rehab App Spun out of CSIRO eHealth Division

2017年09月19日 AM08:09
このエントリーをはてなブックマークに追加


 

BRISBANE, Australia

An Australian solution to dramatically improve recovery from a heart attack today became reality.

Cardihab’s technology platform was developed by scientists at the Australian eHealth Research Centre (AEHRC), a joint venture between CSIRO and the Queensland Government. Cardihab was spun-out from CSIRO after raising venture capital investment of $1.35 million in the new company.

In Australia someone has a heart attack every nine minutes, however less than one third of survivors follow through with cardiac rehabilitation, resulting in up to a 50% chance of being readmitted to hospital in the following year.

Cardihab is a smartphone app connected to a clinic based portal, used for remote patient management following a cardiac event. The app gives clinicians the ability to deliver more convenient, flexible and engaging cardiac rehabilitation meaning better outcomes for patients, clinicians and health service administrators.

Cardihab’s model of care is backed by a randomised control trial that was conducted by CSIRO and the Metro North Brisbane Health and Hospital Service, and published in the international journal Heart. The trial demonstrated that the Cardihab model of care was clinically equivalent to normal care, but significantly improved patient uptake, adherence and completion of cardiac rehabilitation.

Cardihab was able to demonstrate there was no additional benefit for patients who receive face to face care, compared to patients whose cardiac rehabilitation was carried out by a clinician remotely.

Cardihab Chief Technology Officer Simon McBride was part of the team that has been developing and trialling the technology while undertaking research at the AEHRC. “Today’s investment gives us the platform on which to build the company and make a difference to the lives of millions of Australians,” McBride said.

Of the $1.35 million invested in Cardihab, $500,000 has come from Uniseed, a venture fund operating at the Universities of Melbourne, New South Wales, Sydney, Queensland and CSIRO.

The remaining investment is made by private cardiology groups, and existing Cardihab shareholder Artesian Capital.

Cardihab is led by recently appointed CEO Gus Taddeo, who was formerly Managing Director of Cook Medical Australia.

View source version on businesswire.com: http://www.businesswire.com/news/home/20170918006531/en/

CONTACT

WE Buchan
Ben Walsh, + 61 411 520 012
bwalsh@buchanwe.com.au

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • Exactech Earns Research Award at International Computer-Assisted Surgery Conference for ExactechGPS® Knee Application
  • 火山噴火で家屋の破壊と住民の避難が続く中、ハワイ・コミュニティ財団が支援基金を創設
  • Octapharma宣布Nuwiq®产品新增剂量规格在欧洲获准,提高了血友病A患者的给药灵活性
  • PHCホールディングス株式会社:薬剤師の業務効率化を目指した保険薬局用電子薬歴システム「PharnesV-MX」を販売開始
  • LG化学举办“全球创新大赛 (GIC)”“寻找改变世界的创新技术”